Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 3Q:25 results, confirming the pre-new drug application (NDA) meeting with the FDA in 4Q:25 to see if an NDA can be accepted using existing ...
Being a part of what makes Purdue excellent prepares you for future experiences where you will need to present and apply your work. Being directly involved in the process of discovery, along with the ...
Diality Inc. today announced that three posters highlighting new data from the first clinical use of the Moda-flx™ Hemodialysis System will be presented during the American Society of Nephrology’s ...
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced ...
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to ...
MILAN (AP) — The Milan-Cortina 2026 Olympic organizing committee on Wednesday unveiled two official posters for the Winter Olympic and Paralympic Games — bold graphic depictions that officials said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback